col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


14 Ergebisse       Seite 1

 [1] 
SciVision Publishers LLC: Medicine and Clinical Science
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2025―Feb―13 In 2011, after the end of the 2009 new influenza epidemic, four diseases, Kawasaki disease (KD), hand-foot-and-mouth disease, erythema infectiosum, and aseptic meningitis, occurred simultaneously in Tokyo, but in 2024, after the COVID-19 pandemic ended, the incidence of KD was suppressed by the outbreak of Mycoplasma pneumoniae, resulting in the simultaneous occurrence of three diseases other than KD Akira Awaya, Yoshiyuki Kuroiwa
2 [GO] 2025―Jan―02 Vulnerability of Blood Type “A” to Coronavirus Delta Strain Ayoub A Bazzaz, Muhammad E Musa, Saad A Yassin, Emad E Muhammad, Noorhan A Chelebi
3 [GO] 2023―Sep―18 Recent Studies on the Mechanisms and Adverse Effects of Medications Used in COVID-19 Patients Magdy A Ibrahim,, Mir Monir Hossain,, Muhammad Kamal Hossain, Md Hasibur Rahman, et al. (+2)
4 [GO] 2023―Sep―18 Can Leukoerythroblastic Activation Indicate Coronavirus Infection? Noorhan A Chelebi,, Abu-Bakr Al-Ani, Susan J Ali,, Ayoub A Bazzaz, Nada T Al-Basheer
5 [GO] 2023―Jul―19 Annual All-Cause Mortality Rate in Germany and Japan (2005 to 2022) With Focus on The Covid-19 Pandemic: Hypotheses And Trend Analyses Hagen Scherb, Keiji Hayashi
6 [GO] 2023―Jul―19 Letter Rejoinder: “Körblein A. Letter Re: ‘Annual All-Cause Mortality Rate in Germany and Japan (2005 to 2022) With Focus on The Covid-19 Pandemic: Hypotheses And Trend Analyses. Med Clin Sci. 2023; 5(2):1-7.’ By Scherb H, Hayashi K.” Med Clin Sci. 2023; 5(3):1-1. Hagen Scherb, Keiji Hayashi
7 [GO] 2023―Jul―19 Letter Re: “Annual All-Cause Mortality Rate in Germany and Japan (2005 to 2022) With Focus on The Covid-19 Pandemic: Hypotheses And Trend Analyses. Med Clin Sci. 2023; 5(2):1-7.” By Scherb H, Hayashi K Alfred Körblein
8 [GO] 2023―Jul―19 COVID-19 Preoperative Blood Tests : What Do They Tell Us About COVID-19 Vaccines? Laurent Dupoirieux
9 [GO] 2022―Jul―13 Clinical, Biochemical, and Echocardiographic Characteristics of Severe SARS-COV-2 Infection: Correlates of In-hospital Morbidity and Mortality Sabha Bhatti, Varun Bhasin, Justin Johannesen, Ikenna Erinn, Kulin Shah, Anup Regunathan, et al. (+2)
10 [GO] 2022―Jul―12 Repurposing quinine for severe COVID-19 - A preliminary study Bisi Bright, William Remak, Stephanie A Kolakowsky-Hayner, Wael Ali, Niyi Fajimi, Toyin Adesope, et al. (+4)
11 [GO] 2022―Mrz―10 Role of Melatonin in Curtailing Oxidative Stress during COVID-19 Felix Polyak, Roman Rozencwaig, Anna Veksler, Eugene Paransky
12 [GO] 2022―Mrz―10 Overview of COVID-19 cases in the USA and Globally Israr Khan, Faris Naffa, Edzelle Hankins, Chhaya Kamwal, Cinthya Aviles, Sruthi Sekaran, et al. (+7)
13 [GO] 2022―Mrz―10 An observational study of invasive mechanically ventilated critically ill SARS-CoV-2 patients Ricardo Sanchez Garcia,, Frank Hansen, Mariusz Boczan, Karsten Wiborg,, et al. (+3)
14 [GO] 2020―Okt―19 Minimally Invasive Autopsy: a more feasible and safer alternative to conventional autopsy in the COVID-19 pandemic era? Natalia Rakislova, Mamudo R Ismail, Antonio Martinez, Carla Carrilho, Miguel J Martinez, Quique Bassat, et al. (+2)
 [1] 

14 Ergebisse       Seite 1



[de][en]

Letzte Änderung 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.004 sec